University of Kentucky
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kentucky sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
University of Kentucky: 54 sponsored US clinical trials, 5 recruiting.
University of Kentucky sponsors 54 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 41 completed. 4 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Methamphetamine Abuse, with 2 trials.
Top-decile sponsor footprint
University of Kentucky ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
41 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
54 total, page 2 of 2
Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses
NCT00632957
Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure
NCT00255931
Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
NCT00382954
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
NCT00003425
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 2 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the University of Kentucky pipeline
5 recruiting of 54 indexed (9% open); 41 completed (76%).
Phase mix: 4 late (III/IV) vs 16 early (I/II) (early-phase heavy).
Top condition: Methamphetamine Abuse (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kentucky: open-pipeline peers nationwide
Peers matched on 54 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
University of Kentucky sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 trials (± recruiting share)
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
- Auburn University · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Shionogi · 9% recruiting · 54 trials
- University of Vermont · 9% recruiting · 162 trials
- Eli Lilly and Company · 9% recruiting · 1,341 trials
- Lahey Clinic · 9% recruiting · 43 trials
Related
What to do with this University of Kentucky page
54 registered trials is a research-attention snapshot, not an endorsement of University of Kentucky or any single study.
- 5 of University of Kentucky's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Methamphetamine Abuse is the condition University of Kentucky studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Methamphetamine Abuse trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Kentucky pipeline card: 54 registered trials from official public datasets.Report a data error.